Comments
U.S. Court rules Merck's Zetia patent valid
28.04.2012. | (Reuters) - A U.S. court on Friday ruled that the patent on Merck & Co's cholesterol fighter Zetia and a related drug Vytorin was valid and issued an injunction blocking approval of a generic version by Mylan Inc until the patent expires....
